Regenxbio (RGNX) Gross Profit Growth (5y) (2019 - 2024)
Powered by 
Analysis
Regenxbio (RGNX) Gross Profit Growth (5y) (2019 - 2024) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Regenxbio | 472.74 Mn | 367.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 13.30% |
| Sep 30, 2024 | -0.66% |
| Jun 30, 2024 | 14.50% |
| Mar 31, 2024 | 67.70% |
| Dec 31, 2023 | -21.97% |
| Sep 30, 2023 | 28.11% |
| Jun 30, 2023 | -21.91% |
| Mar 31, 2023 | -35.05% |
| Dec 31, 2022 | 122.95% |
| Sep 30, 2022 | 83.04% |
| Jun 30, 2022 | 24.61% |
| Dec 31, 2021 | 194.38% |
| Sep 30, 2021 | 176.57% |
| Jun 30, 2021 | 39.34% |
| Mar 31, 2021 | 107.71% |
| Dec 31, 2020 | 20.32% |
| Sep 30, 2020 | 136.77% |
| Jun 30, 2020 | 54.56% |
| Mar 31, 2020 | 87.70% |
| Dec 31, 2019 | 47.46% |